Note: Ingredients listed on restricted chemical lists
General Information
Product name
Zidovudine Tablets USP, 300 mg
1.2.1 Relevant identified uses
Zidovudine Tablets indicated for the treatment of HIV-l infection
Manufacturer Name
Hetero labs limited
Icons in SDS
Company Information
company name
Camber Pharmaceuticals, Inc
Section 2
Hazard statements
May damage the unborn child. Suspected of causing cancer. Suspected of causing genetic defects Obtain special instructions before use. Known Clinical Adverse effects associated with therapeutic use include blood system changes, Effects: liver effects, heart muscle damage (cardiomyopathy).
